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Bdnf knockout miceNeurotrophins promote the survival of speciﬁc types of neurons during development and ensure proper
maintenance and function of mature responsive neurons. Signiﬁcant effects of BDNF (Brain-Derived
Neurotrophic Factor) on pain physiology have been reported but the contribution of this neurotrophin to the
development of nociceptors has not been investigated. We present evidence that BDNF is required for the
survival of a signiﬁcant fraction of peptidergic and non-peptidergic nociceptors in dorsal root ganglia (DRG)
postnatally. Bdnf homozygous mutant mice lose approximately half of all nociceptive neurons during the
ﬁrst 2 weeks of life and adult heterozygotes exhibit hypoalgesia and a loss of 25% of all nociceptive neurons.
Our in vitro analyses indicate that BDNF-dependent nociceptive neurons also respond to NGF and GDNF.
Expression analyses at perinatal times indicate that BDNF is predominantly produced within sensory ganglia
and is more abundant than skin-derived NGF or GDNF. Function-blocking studies with BDNF speciﬁc
antibodies in vitro or cultures of BDNF-deﬁcient sensory neurons suggest that BDNF acts in an autocrine/
paracrine way to promote the early postnatal survival of nociceptors that are also responsive to NGF and
GDNF. Altogether, the data demonstrate an essential requirement for BDNF in the early postnatal survival of
nociceptive neurons.lular, Universidad de Valencia,
3 543404.
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Dorsal root ganglia (DRG) contain different classes of primary
sensory neurons, such as large proprioceptive neurons, mid-size
mechanoreceptors, and small-diameter nociceptors (see reviews in
Scott, 1992). This cellular diversity is generated during development
by the actions of instructive signals and sequential combinations of
transcription factors that control speciﬁcation of the various neuronal
subtypes (Hippenmeyer et al., 2004; Marmigère and Ernfors, 2007).
Neurogenesis is followed by a selection process modulated by
members of the NGF and GDNF-families of neurotrophic factors, in
which many of the initially generated neurons are eliminated (Huang
and Reichardt, 2001; Kirstein and Farinas, 2002). Different sensory
neurons depend on speciﬁc neurotrophic factors for their survival
during embryogenesis, as demonstrated by analyses in mice carrying
targeted mutations in genes coding for the different neurotrophic
factors or their corresponding receptors. Some neurons, such as
proprioceptors, appear to depend exclusively on one neurotrophin
whereas others seemingly depend on the sequential action of more
than one neurotrophic factor for survival, such as in the case of
nociceptive neurons (see Kirstein and Farinas, 2002).Cutaneous nociceptive neurons which transmit painful stimuli and
have unmyelinated C-ﬁbres can be classiﬁed into two groups
depending on their neurochemistry, connectivity, and physiology
(Hunt and Mantyh, 2001). Approximately half of all small DRG
neurons are peptidergic, containing calcitonin gene-related peptide
(CGRP) and substance P (SP). Non-peptidergic small sensory neurons
can be recognized by their labeling with the Griffonia simplicifolia
lectin IB4 or the FRAP histoenzymatic reaction, and by expression of
the purinergic receptor P2X3 and of the product of the Mrgprd locus
(Bradbury et al., 1998; Vulchanova et al., 1998; Hunt and Mantyh,
2001; Zylka et al., 2005). Moreover, peptidergic and non-peptidergic
neurons project to distinct laminae in the dorsal spinal cord and to
speciﬁc layers and structures within the skin (Molliver et al., 1995;
Hunt and Mantyh, 2001; Zylka et al., 2005). Although peptidergic and
non-peptidergic neurons appear to respond to noxious heat,
responses are physiologically distinct (Stucky and Lewin, 1999) as
they appear to mediate inﬂammatory and neuropathic pain, respec-
tively (see Hunt and Mantyh, 2001; Marmigère and Ernfors, 2007).
During mouse embryogenesis, all small DRG neurons express
the TrkA receptor and require NGF for survival (Crowley et al.,
1994; Smeyne et al., 1994; Silos-Santiago et al., 1995; White et al.,
1996; Rice et al., 1998). After birth, some nociceptors down-
regulate the expression of peptides and TrkA receptors, become IB4+,
and begin expressing the GDNF tyrosine kinase signaling receptor Ret
(Silos-Santiago et al., 1995; Molliver et al., 1997; Bennett et al., 1998).
Although neonatal lethality of the GDNF mutant strain had precluded
to assesswhether GDNFwas indeed essential for the postnatal survival
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these Ret-positive neurons could respond to GDNF (Molliver et al.,
1997; Bennett et al., 1998) led to propose that a fraction of NGF-
dependent embryonic neurons switched dependence to GDNF for
survival after birth (Molliver et al., 1997).More recently, the role of Ret
signalling in the postnatal development of sensory neurons has been
analyzed in mice carrying a speciﬁc deletion of the Ret gene in DRG
neurons (Luo et al., 2007). The phenotype of this conditional knockout
has indicated that Ret signalling is not required for DRG neuron
survival but is necessary for the proper differentiation of the non-
peptidergic nociceptive subtype, as it appears to promote the
expression of several markers that are characteristic of these sensory
neurons and to support the normal extent of their peripheral
projections in the skin (Luo et al., 2007). These recent data have
revived the issue of how survival of the nociceptive neurons that
down-regulate TrkA levels is modulated during early postnatal
development.
Actions of neurotrophic factors are not restricted to the regulation
of neuronal survival during embryogenesis, as neurotrophic mole-
cules also regulate the physiology of mature sensory neurons and
nociceptors are also a good example of the involvement of neuro-
trophins in maturity. For example, NGF regulates the expression of
several molecules involved in neurotransmission and modulates
inﬂammatory pain in adult animals (see, for example, Mendell et al.,
1999; Pezet and McMahon, 2006). Adult nociceptors also respond to
BDNF. This neurotrophin is expressed by TrkA-positive small DRG
neurons (Wetmore and Olson, 1995; Barakat-Walter, 1996; Apfel
et al., 1996; Michael et al., 1997) and is released in the dorsal horn
where it modulates nociceptive processing in cases of inﬂammatory
pain (Kerr et al., 1999; Mannion et al., 1999). The generation of mice
with a targeted null mutation in the Bdnf gene (Ernfors et al., 1994a;
Jones et al., 1994) provided the opportunity to investigate essential
actions of BDNF on the survival of speciﬁc types of neurons, including
nociceptors. However, initial characterizations in various BDNF-
deﬁcient strains of mice were contradictory and the complete sensory
phenotype of animals lacking BDNF remained elusive. Recent reports
have underscored the relevance of BDNF in the survival of certain
types of mechanoreceptors (Fundin et al., 1997; Ichikawa et al., 2000;
Alkhamrah et al., 2003; Gonzalez-Martínez et al., 2004, 2005; Sedý et
al., 2004), but analyses of DRG nociceptors in these animals have
never been reported.
In the present analysis we have used a previously characterized
strain of Bdnf mutant mice to analyze whether nociceptive neurons
require BDNF for their survival. We have found that lack of BDNF
results in the postnatal loss of a considerable fraction of nociceptive,
both peptidergic and non-peptidergic, unmyelinated afferents in vivo
at times when BDNF is highly expressed within the ganglia. In vitro
analysis of the trophic requirements of neonatal DRG small neurons
suggests that BDNF is required in an autocrine/paracrine fashion by
murine nociceptive neurons that are also responsive to NGF and
GDNF, during the ﬁrst week of postnatal life. Our results indicate that
nociceptive neurons which down-regulate TrkA immediately after
birth require BDNF for their survival.
Material and methods
Animals
The generation and genotyping of mice with targeted mutations in
the Bdnf gene used in this study have been described elsewhere (Jones
et al., 1994). Animal housing and all experiments were performed
according to the animal care guidelines of the European Community
Council (86/609/EEC) and to Spanish regulations (RD1201/2005),
following protocols approved by the ethics committee of the
Universidad de Valencia. Timed embryos were obtained by overnight
mating of heterozygotes and the morning of the vaginal plug wasconsidered embryonic (E) day 0. Pregnant females at different stages
of gestation (E12, E15) were sacriﬁced by cervical dislocation and
embryos dissected out.
Histological procedures
Deeply anesthetized adult and postnatal animals were transcar-
dially perfused with 4% paraformaldehyde (PFA) in PB (0.1 M
phosphate buffer, pH 7.4), placed immediately into the same ﬁxative
for a few hours and then thoroughly washed with PBS (0.9% sodium
chloride in PB, w/v). Embryos were ﬁxed in Carnoy's ﬁxative (60%
ethanol, 30% chloroform, 10% acetic acid, v/v). For cell counts,
complete embryos and the lumbar region of neonatal animals were
embedded in parafﬁn and serially sectioned at 7 μm, as previously
described (Fariñas et al., 1996). At E12, complete series through the
embryos were immunostained with antibodies to 150-kDa neuroﬁla-
ment subunit (anti-NF; Chemicon 1:500), because at this stage
neurons and neural precursors cannot be distinguished based solely
on morphology. At E15, P0, and P15, neurons were identiﬁed using
morphological criteria in 0.1% cresyl violet-stained sections. In all
cases, only cells with clearly identiﬁable nucleoli were counted in
every fourth section to calculate the total number present in each
ganglion. For immunohistochemistry, footpads, lumbar DRGs, and
spinal cords were cryoprotected in 30% sucrose in PB (w/v), frozen
with dry ice, and sectioned transversally at 10 μm or at 20 μm (skin)
using a Leica CM1900 cryostat. For ﬁbre counts in adult or P15
animals, L3–L5 dorsal roots or sciatic nerves and different segments
of the saphenous nerve were isolated, postﬁxed with 1% osmium
tetroxide in PB (w/v) for 90 min at room temperature (20–25 °C),
dehydrated through a graded ethanol series followed by propylene
oxide, and embedded in araldite (Durcupan, Fluka). Nerves were
cross-sectioned at 1 μm and sections stained with 1% toluidine blue
(w/v) for counts of myelinated ﬁbres at the light microscope.
Ultrathin 60 nm-thick sections were collected on formvar-coated
slot grids, stained with uranyl acetate and lead citrate, and
examined with a Jeol JEM-1010 electron microscope. The total
number of C-ﬁbres per nerve was estimated by counting the
number of unmyelinated nerve ﬁbre proﬁles in a number of
randomly chosen electron micrographs (at a 5200×magniﬁcation)
comprising around 50% of the total cross sectional area and referring
this count to the total area of the corresponding nerve. Cross-
sectional areas of unmyelinated axons in electron micrographs as
well as cross-sectional areas of nerve segments at the light micro-
scopy level were determined using the Visilog© Image Analysis
Software Package.
Immunohistochemistry and lectin histochemistry
For inmunocytochemistry and lectin histochemistry, sections were
blocked in PB containing 10% fetal bovine serum (FBS) (v/v), 1%
glycine (w/v), and 0.2% Triton X-100 (v/v) and left overnight at 4 °C
in the same blocking solution with rabbit antibodies to PGP 9.5
(UltraClone, 1:1000), rabbit antibodies to CGRP (Amersham, 1:500),
or with biotinylated lectin from Griffonia simplicifolia IB4 (Sigma,
10 μg/ml). For ﬂuorescent detection, sections were washed with PB
several times and incubated for 45 min in Cy3-conjugated goat-anti-
rabbit (Jackson InmunoResearch Labs., 1:2500) and/or Alexa 488-
conjugated donkey anti-rabbit antibodies (Molecular Probes, 1:500),
or in Cy2-conjugated streptavidin (Jackson InmunoResearch Labs.,
1:200). Sections were mounted with Fluorsave ﬂuorescent mounting
medium (Calbiochem). For peroxidase-based detection of anti-NF
antibodies in embryonic DRGs, primary antibody incubation was
followed by appropriate biotinylated secondary antibodies and
reagents of the ABC kit (Pierce) following manufacturer's recommen-
dations. Peroxidase was reacted with 0.05% diaminobenzidine (w/v)
and 0.003% hydrogen peroxide (v/v).
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Four- to ﬁve-month-old Bdnf heterozygous mice and their wild-
type littermates were tested for thermal nociception. Mice were
group-housed divided by gender and the same number of females and
males were distributed in every experimental group. Pain sensitivity
was measured using the hot plate latency test of thermal pain on a
standard hot plate 50 (±0.1) °C connected to an electronic timer with
0.1 s precision (Panlab Instruments, Spain). Mice were placed
individually on a 22×22 cm plate surrounded by 45 cm cylinder
Plexiglas walls and responses such hind-paw licking, four-paw
jumping and hind-paw lifting were recorded as measures of pain
sensitivity (Cirulli et al., 2000). Mice were removed from the hot plate
immediately after showing a pain response and the timewas recorded
as the hot plate latency. Unresponsive mice were removed 40 s after
being placed in the hot plate apparatus to prevent tissue damage and
these mice were assigned a time latency of 40 s. The hot plate test was
performed and videotape recorded by an experimenter unaware of
the genotypes.
DRG neuron culture
Wild-type mice of different postnatal ages (P0, P2, P5, P7 or P15)
were decapitated, and approximately 50 DRGs were dissected out
from each one of them and collected in L15 media. Ganglia were
incubated at 37 °C with 2 mg/ml collagenase (Worthington) followed
by 0.05% trypsin (Sigma). Approximately 2000 neuronswere plated in
1 ml of deﬁned medium, consisting of Hams F12 supplemented with
2 mM glutamine, 0.35% bovine serum albumin (Pathocyte-4, ICN,
Irvine, CA) (w/v), 60 ng/ml progesterone, 16 μg/ml putrescine,
400 ng/ml L-thyroxine, 38 ng/ml sodium selenite, 340 ng/ml
triiodothyronine, 60 μg/ml penicillin and 100 μg/ml streptomycin,
using 24-well plates (Orange) with 12-mm coverslips that had been
previously coated with poly-ornithine (0.5 mg/ml, overnight) and
laminin (20 μg/ml, 4 h) (Davies et al., 1993). Four hours after plating,
the total number of attached cells per well with a clear neuronal
morphology under phase-contrast optics was estimated by counting
them in non-overlapping ﬁelds along two perpendicular lanes
through the center of each coverslip. These counts were taken as
measurements of the initial number of neurons plated and only those
experiments with comparable initial numbers were used for quanti-
tations. Neurotrophic factors NGF, BDNF, and GDNF (Peprotech) were
used at a 10 ng/ml concentration, either alone or in combinations. The
control condition was obtained by culturing the neurons in the
absence of any growth factor. Neurons were maintained in culture at
37 °C in a humidiﬁed incubator under 5% CO2 and total numbers of
surviving neurons were estimated after different times, as previously
explained. For blocking experiments, neonatal DRG neurons were
cultured in 10 ng/ml NGF in the presence of 6 μg/ml of rabbit anti-
BDNF antibodies (Santa Cruz Labs) or rabbit anti-mouse IgGs (Sigma)
as controls and numbers of surviving neurons were determined after
10 days in vitro. For immunolabelings and counts of speciﬁc
populations, some cultures were ﬁxed for 20 min with 4% PFA in
PB, followed by three rinses in PB, and an incubation with 10% FBS
and 0.2% Triton X-100 in PB (blocking buffer) for 30 min at room
temperature. For the detection of TrkB, coverslips were incubated
overnight at 4 °C with chicken anti-TrkB (1:10; Promega) in
blocking buffer, followed by biotinylated anti-chicken antibodies
(1:300, Promega) and Cy2-conjugated streptavidin (1:100; Jackson
InmunoResearch Laboratories Inc.). Some cultures were labeled with
rabbit anti-CGRP (1:1000; Amersham) or with biotinylated IB4
lectin (10 μg/ml; Sigma) followed by secondary biotinylated anti-
rabbit antibodies for 45 min (1:500; Jackson InmunoResearch Labs.,
or) and ABC-peroxidase (Pierce) or with the ABC reagents,
respectively. Peroxidase was reacted with 0.05% diaminobenzidine
and 0.003% hydrogen peroxide. For double-labeling immunoﬂuores-cent detection, Cy3-conjugated anti-rabbit (1:2500) and Cy2-
conjugated streptavidin (1:100) (Jackson InmunoResearch Labora-
tories Inc.) were used, followed by DAPI staining and Fluorsave
mounting.
Real-time quantitative PCR
P0, P7 and P15 mice pups (n=3 for each stage) were decapitated
and all DRGs were quickly removed. The same quantity of shaved skin
was dissected at the upper thigh level of each animal. Total RNA was
isolated using Trizol (Life Technologies, Gaithersburg, MD) extraction
followed by isopropanol precipitation. The resulting RNA was
reconstituted in 100 μl of RNase-free water. The RNA content was
measured with a spectrophotometer and only those samples with a
260/280 ratio of N1.6 were used. Samples were DNased and 3 μl of
total RNA were reverse-transcribed with Superscript II reverse
transcriptase and random primers (Invitrogen) in a 20 μl reaction
volume and RT− of each sample was used as control for DNA
ampliﬁcation. The reaction was performed at 42 °C for 50 min
followed by 15 min at 70 °C. For PCR reactions cDNA products were
diluted 1:5. Real-time quantitative PCR was performed using an ABI
PRISM 7700 sequence detection system (Applied Biosystems) and
QuantiTect SYBR green PCR kit (Qiagen). All PCR reagents were
premixed to optimize concentrations and minimize pipetting errors.
Themeasurements were carried out in a 96-well optical reaction plate
(Applied Biosystems). For each well, the 26 μl reaction volume
contained: 12.5 μl of QuantiTect SYBR green PCR master mix, 0.3 μM
each forward and reverse primer, 11 μl of H2O and 1 μl template cDNA.
All samples were ampliﬁed at 35 cycles which is beyond the beginning
of the linear phase of ampliﬁcation. The cycling conditions were: an
initial melting step was done at 50 °C for 2 min and at 95 °C for 10 min
followed by 35 cycles of 95 °C melting step for 30 s, an annealing step
(60 °C for BDNF and 59 °C for GDNF or NGF) for 45 s and 72 °C
elongation step for 1 min. β-Actin mRNA was also measured in the
same reaction as an internal control with two different actin primers
depending on the annealing temperature of each sample. Primers
were designed with the Primer Express 2.0 program. They were as
follows: NGF (forward, 5′-GATCGGCGTACAGGCAGAAC; reverse, 5′-
CAGTGGGCTTCAGGGACAGA), GDNF (forward, 5′-AGCCACCAT-
TAAAAGACTGAAAAGG; reverse, 5′-CCTGCCGATTCCTCTCTCTTC),
BDNF (forward, 5′-CCAAAGGCCAACTGAAGCAGTA; reverse, 5′-
GCAGCCTTCCTTGGTGTAACC), β-actin 60 °C (forward, 5′-CGGGACCT-
GACAGACTACCTCAT; reverse, 5′-GCCATCTCCTGCTCGAAGTCTAG),
β-actin 59 °C (forward, 5′-CCGGGACCTGACAGACTACCT; reverse,
5′-GCCATCTCCTGCTCGAAGTCTA). In all experiments, samples
containing no template were included as negative controls. To
determine the relative concentration of the target transcript, a
standard curve was run in duplicate with puriﬁed, quantiﬁed and
serially diluted genomic DNA from mouse tissue. All samples, non-
template controls, standard curve and internal controls, loaded in
triplicate (except standard), were tested simultaneously for each
primer. Reproducibility of the results was conﬁrmed by running two
PCR reactions for each experiment. Quantiﬁcation of mRNA in each
sample was determined by analysis with ABI Prism 7000 SDS
Software. The PCR reaction for TrkB ampliﬁcation was performed
in a Mastercycler (Eppendorf) with 35 cycles of denaturation
(94 °C, 30 s), annealing (56 °C, 45 s), and elongation (72 °C, 1 min)with
appropriate primers (forward, 5’-GCGAACCTGCAGATACCCAAT;
reverse, 5’-CCAAATTCCCAACGTCCCA).
Statistical analyses
All values are expressed as the mean±SEM and for some
experiments values were normalized to the mean level of vehicle-
treated control group. For each experiment, the number of indepen-
dentmice or cell cultures is indicated as "n". Differences amongmeans
Table 2
Myelinated and non-myelinated ﬁbre counts in dorsal roots and in cutaneous nerves of
P15 Bdnf+/+ and Bdnf−/− mice.
Bdnf+/+ Bdnf−/− % reduction
Myelinated ﬁbres
L3 dorsal root 1473±42 987±89 32⁎
L5 dorsal root 2490±108 1600±39 36⁎
Saphenous nerve 545±29 386±27 29⁎
Non-myelinated ﬁbres
L5 dorsal root 6516±830 3313±339 49⁎
Saphenous nerve 3325±358 1604±189 48⁎
Myelinated ﬁbres were counted in 1 μm thick transverse nerve sections stained with
toluidine blue. Non-myelinated ﬁbres were estimated in electron micrographs (see
Material & Methods). Three independent animals were analyzed in each case and data
are presented as mean±SEM.
⁎ Pb0.05.
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transformation was applied for comparisons between relative values
(normalized values and percentages). Signiﬁcance was set at ⁎Pb0.05,
⁎⁎Pb0.01, or ⁎⁎⁎Pb0.001.
Results
Postnatal loss of nociceptive sensory cutaneous afferents in Bdnf null mice
Initial studies in the strain of BDNF-deﬁcient mice used here
indicated that DRG neuron numbers were reduced up to 30% two
weeks after birth (Jones et al., 1994; see also, Ernfors et al., 1994a for
data on a different strain). In the present study we counted numbers
of DRG neurons in lumbar (L)1 and L4 ganglia of Bdnf+/+ and Bdnf−/−
animals at different stages to determine the timing of this sensory
neuron loss. We found no signiﬁcant loss of DRG neurons in the Bdnf
homozygous mutant mice during embryogenesis or at birth; however,
we could conﬁrm that the loss was evident 15 days after birth, when
almost 40% of the neurons were lost in animals lacking BDNF (Table 1).
Therefore, despite the presence of TrkB protein in a signiﬁcant number
of DRG neurons during embryonic development (Fariñas et al., 1998),
the requirement for BDNF by DRG sensory neurons appeared to be
entirely postnatal.
Myelinated ﬁbres in transverse sections through the L3 and L5
dorsal roots were also reduced in number up to 30%–35% in Bdnf−/−
animals at P15 (Table 2; Figs. 1A, B) (see also, Jones et al., 1994).
Because more than half of the ﬁbres in a sensory nerve have small
caliber and are notmyelinated (Harper and Lawson, 1985; Hulsebosch
et al., 1986) and, therefore, not visible at the lightmicroscopy level, the
fact that equal percentages ofmyelinated ﬁbres and of cell bodieswere
missing in Bdnf−/− animals suggested that neurons with unmyelin-
atedﬁbreswere also compromised in the absenceof this neurotrophin.
To determine whether the lack of BDNF resulted in changes in the
number of neuronswith C-ﬁbres, we studied the L3 and L5 dorsal roots
and the purely cutaneous saphenous nerve of Bdnf+/+ and Bdnf−/−
P15 mice at the electron microscopy level. Bundles containing
unmyelinated ﬁbres were normally found intermingled with the
myelinated afferents (Figs. 1C, D). The groups of C-ﬁbres in Bdnf−/−
dorsal roots and nerves were observed at an apparently normal
frequency and the average cross sectional area of individual C-ﬁbres
did not differ between genotypes (Bdnf+/+: 0.13±0.02 μm2 vs.
Bdnf−/−: 0.14±0.01 μm2), but in BDNF-deﬁcient animals the
bundles included fewer ﬁbres (9.7±0.7 in Bdnf+/+ and 6.9±0.2
in Bdnf−/− P15 mice, n=3 independent animals per genotype,
Pb0.01; Figs. 1C, D). Estimation of the total number of unmyelinated
ﬁbres per nerve indicated a reduction of almost 50% both in dorsal
roots and in the purely cutaneous saphenous nerve of BDNF-deﬁcient
P15 mice (Table 2).
Because Bdnf−/− mice do not thrive and most die during the ﬁrst
few days of postnatal life (Jones et al., 1994), we also analyzed
nociceptive ﬁbres and pain behavior in adult heterozygous Bdnfmice.
Our results indicated that heterozygous Bdnf adult mice lack someTable 1
Neuronal counts in DRGs of Bdnf+/+ and Bdnf−/− mice.
E12 E
L1 DRG Bdnf+/+ 2510±227 (6) 5
Bdnf−/− 2470±266 (2) 5
L4 DRG Bdnf+/+
Bdnf−/−
% reduction n.s. n
Neurons were counted in series of sections through the lumbar L1 and L4 DRGs of wild-typ
were calculated by counting neuroﬁlament-positive cells. At older stages, neurons identiﬁed
as mean±SEM. The number of individual animals analyzed in each case is indicated in paren
t test: ⁎ Pb0.05; n.s. not signiﬁcant. P15 data are in agreement with previously published dnociceptive neurons compared to wild-typemice as reﬂected by a 25%
reduction in the number of unmyelinated ﬁbres in the sciatic nerve of
mutant vs. wild-type animals in electron micrographs (Bdnf+/+:
9568±826, Bdnf+/−: 7099±148, n=3 independent animals per
genotype; Pb0.05). Consistent with this loss, nociceptive analyses
using the hot plate test indicated that Bdnf+/− mice are slower in
their latency to lick or lift their hind paw and to jump from the hot
plate when set at 50 °C, compared to their wild-type counterparts
(Figs. 1E, F). Although these higher latencies have been previously
related to effects of BDNF in centrally mediated pain responses
(MacQueen et al., 2001), our data suggest that a loss of nociceptors is
also likely to underlie pain hyposensitivity in animals with low BDNF.
As described for other neurotrophin mutant strains, the Bdnf
heterozygous condition has an intermediate phenotype between
wild-type and homozygous mutants, suggesting that the amount of
neurotrophin produced in vivo is indeed limiting (Kirstein and
Farinas, 2002).
Unmyelinated afferents with C-ﬁbres terminate as free endings in
the epidermis (Lynn and Carpenter, 1982; Willis and Coggeshall,
1991). To evaluate overall skin innervation histologically, we
immunostained sections through footpad glabrous skin and back
hairy skin with antibodies to PGP9.5, a general marker for peripheral
ﬁbres, and to CGRP. In agreement with signiﬁcant reductions in the
numbers of arriving cutaneous C-ﬁbres, the density of free PGP9.5+
endings in the epidermis was visibly diminished in both the glabrous
(Figs. 2A, B) and the hairy skin (not shown) of Bdnf−/− mice relative
to wild types at P15. The reduction in the number of DRG neurons
after birth and the accompanying loss of unmyelinated ﬁbres in the
mutant mice demonstrates that BDNF is essential in vivo for the
postnatal survival of some nociceptors.
Unmyelinated nociceptive sensory neurons can be divided into
peptidergic and non-peptidergic subtypes which can be selectively
recognized with antibodies to CGRP/SP and with the lectin IB4,
respectively (Averill et al., 1995; Silos-Santiago et al., 1995; Bennett
et al., 1998). In order to further investigate cell losses within the15 P0 P15
642±457 (4) 6379±460 (5)
432±557 (3) 5814±90 (5)
10,099±137 (3) 8215±1246 (3)
10,234±1311 (3) 5077±301 (4)
.s. n.s. 38⁎
e (Bdnf+/+) and homozygous mutant (Bdnf−/−) mice. At E12, the numbers of neurons
by cresyl violet staining were counted (see Fariñas et al., 1996). Numbers are expressed
thesis. Differences between the two genotypes were tested using a two-tailed Student's
ata in this (Jones et al., 1994) and another (Ernfors et al., 1994a) strain.
Fig. 2. Effect of the lack of BDNF signalling on cutaneous innervation and on different
nociceptors. (A, B) Overall skin innervation of footpad glabrous skin in 15-day-old
Bdnf+/+ and Bdnf−/− mice visualized by immunolabeling with antibodies to PGP9.5.
Nuclear staining is DAPI. Fewer arriving nerves and free nerve endings (arrow heads)
in the epidermis are observed in the Bdnf−/− mice. Epidermal thickness in Bdnf−/−
P15 mice appears slightly reduced compared to that of wild types (in μm: 21.9±1.2
and 27.2±1.6, respectively; n=4, p=0.022). Because mutant pups do not feed well
and are generally smaller, the reduction in skin thickness may not be directly due to
the lack of BDNF. (C–F) Transverse sections of the dorsal horn of the spinal cord of
wild-type and Bdnf-mutant animals labelled with CGRP antibodies (C, D) or IB4 lectin
(E, F). The areas occupied by CGRP+ or IB4+ nerve endings are reduced in mutant
animals and the CGRP collaterals that form the gracile fasciculus are missing in the
Bdnf mutant mice (empty arrow). (G, H) Sections through DRGs showing CGRP+
(red) and IB4+ (green) neurons. A few double-labelled cells (yellow, indicated by
arrows) are present in bothwild-type andmutant animals. (I) The numbers of CGRP+or
IB4+ neurons decrease in P15 Bdnf mutant animals (n=4). ⁎⁎Pb0.005, ⁎⁎⁎ Pb0.001).
Scale bars: A and B, 20 μm; C–F, 100 μm; G and H, 40 μm.
Fig. 1. Loss of nociceptive sensory ﬁbres and pain hyposensitivity in Bdnfmutant mice.
Transverse sections through dorsal roots from Bdnf+/+ (A, C) and Bdnf−/− (B, D) mice
at the light (A, B) and electron (C, D) microscopy levels. (A, B) Cross sections of L5
dorsal roots from Bdnf+/+ and Bdnf−/− mice. Myelinated ﬁbre proﬁles are easily
distinguished at the light microscope by the intense staining of the myelin sheath with
toluidine blue. Notice the area reduction in the root of the mutant. (C, D) Electron
micrographs of transverse sections of L5 dorsal roots from Bdnf+/+ and Bdnf−/−mice.
Unmyelinated ﬁbres are found in bundles (arrows) intermixed with myelinated ﬁbres
of different caliber. Notice that bundles include fewer ﬁbres in the BDNF-deﬁcient
animal. Losses in both, myelinated and unmyelinated axons (see Table 2), contribute to
the size reductions observed in cross sections of dorsal roots from Bdnf-mutant mice.
(E, F) Nociceptive thresholds in Bdnf+/+ and Bdnf+/− adult mice were determined by
measuring latencies (in seconds) of speciﬁc pain responses to heat: hind-paw licking or
jumping (E) and hind-paw lifting (F). The group of Bdnf heterozygous mice showed a
signiﬁcantly increased latency in nociceptive behaviors. ⁎Pb0.05: (E) n=8, (F) n=4
independent animals per genotype. Scale bars: A and B, 25 μm; C and D, 1.5 μm.
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DRGs and spinal cords of 15-day-old wild-type and homozygous
mutant animals for CGRP and IB4. Central projections of these two
nociceptor populations terminate in a distinct laminar pattern in the
dorsal horn of the spinal cord. CGRP-immunoreactive terminals can be
found within lamina I and in the outer region of lamina II (lamina IIo)
whereas IB4-neurons mainly project to inner lamina II (lamina IIi)
(Averill et al., 1995; Silos-Santiago et al., 1995; Molliver et al., 1997;
Zylka et al., 2005). In the spinal cord of Bdnfmutant animals the CGRP-
positive band was smaller and the ﬁbres were slightly disorganized at
the dorsal horn (Figs. 2C, D) and this reduction in CGRP-positive ﬁbres
could also be observed in the gracile fasciculus tract which contains
the ascending collaterals of peptidergic neurons (Kubota et al., 1988).
The reduction in IB4 binding to lamina IIi in Bdnf mutant animals
relative to wild types was even more striking (Figs. 2E, F). CGRP+ and
IB4+ DRG neurons are largely separate populations at P15 and, as
shown in Figs. 2G and H, CGRP- (red) and IB4-positive (green)
neurons were present in DRGs of either genotype. However, neuronal
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population and 50% of the IB4-positive population were missing in
Bdnf-mutant animals compared to wild types (Fig. 2I). All these data
together suggest that both types of nociceptors require BDNF for
survival.
In vitro dependence of small DRG neurons on BDNF
To determine whether BDNF supported sensory neurons which
were also responsive to NGF or to GDNF, DRG neurons from postnatal
animals of increasing age (P0, P2, P5, P8, and P15)were cultured in the
presence of BDNF, NGF, or GDNF, at 10 ng/ml each and in different
combinations of these neurotrophic factors. Dissociated DRG neurons
in each well were counted 4 h after plating, to obtain an estimate of
the number of neurons seeded, and then again after 2 days in vitro
(DIV), to determine the proportion of the neurons that had survived in
each condition. Neurons were seeded at very low density, to avoid
paracrine effects, but even under these stringent conditions there was
a certain degree of neurotrophin-independent survival which became
more signiﬁcant with time and, by P8 (Fig. 3A) and P15 (not shown),
the number of DRG neurons surviving in the absence of exogenously
added growth factors for 48 h was the same as in any of the trophic
conditions tested (Fig. 3A). We, therefore, focused our analysis during
the ﬁrst week of postnatal life.
The highest percentages of surviving neurons (around 80%) at all
stages were obtained in NGF. Only a small percentage of neonatal
neuronswere found to survive in the presence of BDNF or GDNF alone,
although these percentages were progressively higher in P2 and P5
cultures (Fig. 3A) suggesting that increasing numbers of neuronswere
acquiring responsiveness to BDNF and GDNF in vivo during the ﬁrst
postnatal week (Fig. 3A). Neuron morphology in BDNF- and GDNF-Fig. 3. In vitro survival of early postnatal DRG neurons in the presence of different growth fa
after birth (P) and cultured for 48 h in the presence of 10 ng/ml NGF, BDNF, or GDNF, or in
attached neurons 4 h after plating). Notice that neurotrophic factor independence progress
NGF. BDNF or GDNF only support the survival of a relatively small population of neonatal se
increases. P0, n=3; P2, n=12; P5, n=3; P8, n=4. (B) Sensory neurons from P2 mice c
antibodies (green). ⁎Pb0.05, ⁎⁎Pb0.005, ⁎⁎⁎ Pb0.001. Scale bar: 25 μm.treated cultures was not identical, as neurons surviving in GDNF were
signiﬁcantly larger than those surviving in BDNF (Fig. 3B); however,
neurons surviving in the presence of BDNF or GDNF appeared to be
the same as their separate effects were not additive when both factors
were used in combination (Fig. 4A; see also Baudet et al., 2000).
Moreover, BDNF and GDNF responsive neurons could also survive in
NGF (Figs. 4B, C). Therefore, between birth and P5, increasing
numbers of NGF-responsive neurons become also responsive to
either BDNF or GDNF although a fraction of all neurons remain
exclusively responsive to NGF. These results together indicated that
postnatally there is a fraction of NGF-dependent neurons that only
express TrkA and another fraction of TrkA+ neurons which also
express components of the GDNF-signalling complex as well as TrkB.
The latter population increases progressively with time from
approximately 10% of all neurons at P0 to 40% at P5.
Because NGF-responsive neurons became progressively respon-
sive to BDNF in vivo, we next decided to study whether DRG neurons
cultured only in NGF could up-regulate TrkB. In order to do so, we
cultured P2 neurons for either 2 or 4 DIV in NGF and stained them
with anti-TrkB antibodies. Approximately half of the P2 neurons were
TrkB immunopositive after 2 DIV in culture and this percentage
increased when the culture was extended for 2 additional DIV only in
the presence of NGF (Fig. 5A). The observation that the proportion of
sensory neurons exhibiting BDNF responsiveness increases with time
in NGF-treated cultures suggested the possibility that TrkB expression
could be under the regulation of NGF. We plated neonatal DRG
neurons in NGF for 24 h, to support their survival during attachment
and initial growth, and the neurotrophin was eliminated afterwards
by extensive washing. We then performed a 12-h starvation followed
by stimulation with10 ng/ml NGF for different time periods (4, 8, 12,
and 24 h) in two different cultures. The level of TrkB mRNA, asctors. (A) Survival of sensory neurons dissociated from wild-type DRGs at different days
the absence of any added factors (0 NT) (expressed as a percentage of the number of
ively develops after birth. At all stages, maximal survival is obtained in the presence of
nsory neurons but at P2 and P5 the percentage of BDNF and GDNF dependent neurons
ultured in NGF, BDNF, or GDNF, at 10 ng/ml each, and stained with anti βIII-tubulin
Fig. 4. In vitro survival of early postnatal DRG neurons in the presence of different
growth factors. (A-C) Survival of sensory neurons dissociated from wild-type DRGs at
P0, P2, and P5 and cultured for 48 h in the presence of 10 ng/mlNGF, BDNF, or GDNF, and
in combinations of two neurotrophic factors (expressed as a percentage of the number
of attached neurons 4 h after plating). P0, n=3; P2, n=12; P5, n=3. (A) Neurons
respond equally well to GDNF and BDNF and effects are not additive suggesting that
these two factors act on the same population of neurons. A fraction of IB4 neurons can be
sustained by BDNF. (B) GDNF elicits an increasing survival response in a fraction of the
NGF-dependent population. (C) BDNF elicits an increasing survival response in a
fraction of the NGF-dependent population. ⁎Pb0.05, ⁎⁎Pb0.005, ⁎⁎⁎ Pb0.001.
Fig. 5. In vitro expression of the TrkB receptor. (A) Percentage of TrkB-expressing
neurons in cultures from 2-day-old postnatal mice maintained for 48 or 96 h in the
presence of 10 ng/ml NGF. A substantial percentage of neurons cultured in NGF
expressed the TrkB receptor (n=4). (B) Time course of TrkBmRNA expression induced
by treatment with NGF for different periods, as determined by RT-PCR. β-Actin is used
as a control. ⁎Pb0.05.
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NGF (Fig. 5B). Although we can not rule out effects of NGF-promoted
differential survival in the increment in TrkB mRNA levels in our
experiment, the increase, relative to the control situation without
NGF, is already observed as shortly as 4 h after stimulation with NGF
suggesting that TrkB expression is modulated by NGF signalling.
We next investigated the effect of these different factors on the
survival of speciﬁc populations of small DRG neurons. Previous studies
in vitro and in vivo had led to the conclusion that CGRP+ neurons
switched phenotype and became IB4+ and that this change was
accompanied by a switch in neurotrophic dependence from NGF to
GDNF (Silos-Santiago et al., 1995; Molliver et al., 1997). In this
complex scenario, we wanted to analyze the contribution of BDNF to
the survival of these differently evolving populations. Because
immunocytochemical detection of trophic factor receptors critically
depends on the quality of the antibodies and can seldom distinguish
inactive isoforms, we decided to evaluate trophic dependence of
peptidergic and non-peptidergic nociceptors by establishing the
phenotype of the DRG neurons surviving in the different neurotrophic
factors. We concentrated our analysis between P0 and P5 whenneurotrophic dependencies appeared to be changing. DRG neurons
from P0, P2, and P4 animals were grown for 2 DIV in each
neurotrophic condition, and subsequently ﬁxed and processed for
the ﬂuorescent detection of CGRP and of IB4 binding sites. At P0, most
surviving neurons in NGF were CGRP+ (75%±7%; n=3 independent
cultures) and only a fraction (39%±7%, n=4)were IB4+ (Fig. 6A). By
P15, IB4+ and CGRP+ neurons in the culture plate were distinct
separate populations (not shown), similarly to what happens in vivo
(see Fig. 2). Interestingly, NGF appeared to promote the survival of
both CGRP and IB4+ neurons during the whole developmental time
window from P0 to P5. Furthermore, when we analyzed the
contribution of each of the three factors (Fig. 6A) we found that
either one appeared to support the survival of CGRP and IB4+
neurons, an indication that, at these early postnatal times, DRGs
contain peptidergic and non-peptidergic neurons which express TrkA,
TrkB and Ret. These results indicated that receptors for NGF, BDNF and
GDNF family members were present in both populations of sensory
neurons. However, the effect of each neurotrophic factor on the
phenotype of the surviving neurons was not identical. In NGF, double-
labelled CGRP/IB4 neurons were strongly positive for CGRP whereas
in BDNF and GDNF double-labelled neurons appeared to have lower
levels of CGRP (Fig. 6B). Despite our observation that BDNF and GDNF
were maintaining the same neurons, IB4+ neurons cultured in GDNF
appeared larger than those cultured in BDNF suggesting that GDNF
increases neuronal size (Moore et al., 1996; Luo et al., 2007).
Paracrine actions of BDNF on the survival of nociceptors
Given that growth of cultured DRG neurons can be supported to
different extents by the three neurotrophins in vitro, we investigated
which tissues produce them in vivo. Expression levels for NGF, BDNF
and GDNF were examined by quantitative real-time PCR on samples
of hairy ﬂank skin and DRGs from newborn, P8, and P15 mice
(Figs. 7A, B). Expression of the different factors in the skin was low
compared to the expression in the ganglia presumably because, after
ﬁnal innervation, neurotrophic factors are likely to be expressed by
speciﬁc receptor cells rather than by all skin cells. In the skin, the
Fig. 6. In vitro survival of small diameter DRG neurons in the presence of different growth factors. (A) Survival of CGRP+ and IB4+ neurons isolated from DRGs of P0, P2 and P5mice
and cultured for 48 h in the presence of 10 ng/ml each of NGF, BDNF, or GDNF (expressed as a percentage of the number of attached neurons 4 h after plating) (n=5). (B) Double
staining of cultured neurons from DRGs of P5 mice with CGRP antibodies (red) and IB4 lectin (green) in different growth factor conditions. Scale bars: 50 μm.
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progressively declined. BDNF and GDNF mRNAs were also present in
skin samples but in much smaller amounts (Fig. 7A).
Interestingly, BDNF expression in the ganglia was remarkably high
relative to skin samples and the highest among the three neurotrophic
factors, suggesting that DRGs themselves may be a very relevant
source of BDNF at times when nociceptive neurons require this
neurotrophin for survival. BDNF expression in the DRGs was highest
at birth and decreased steadily over the following twoweeks although
it remained high, compared to cutaneous levels, during the ﬁrst two
weeks of postnatal life (Fig. 7B). Our expression studies could not
distinguish whether the source of BDNF in the ganglia is neuronal or
non-neuronal. However, previous reports already demonstrated that
BDNF is produced by TrkA+ DRG neurons in response to NGF (Apfel
et al., 1996; Michael et al., 1997).
The expression pattern for BDNF suggested that sensory neurons
might depend postnatally on this neurotrophin in a paracrine/
autocrine fashion. In order to test this possibility, we performed two
types of experiments. In one type of experimental, we cultured
neonatal DRG neurons at a 10,000 cell/ml density in medium
containing 10 ng/ml NGF alone or in the presence of either anti-
BDNF blocking antibodies or a non-relevant IgG. BDNF-blocking anti-
bodies decreased neuronal survival in NGF affecting both, CGRP and
IB4-positive, neuronal populations (Figs. 8A, B). As a second approach,
we plated DRG neurons obtained from Bdnf+/+and Bdnf−/− neonatalmice in the presence of NGF, BDNF, or GDNF, at 10 ng/ml each, for
48 h. In the presence of BDNF we did not observe any difference
between genotypes in the relative number of surviving neurons, in
agreement with the exogenous administration of the neurotrophin
that mutant neurons are missing. Interestingly, however, a fraction of
the neurons that would normally survive in the presence of NGF or
GDNF were lost when cultures came from mutant relative to wild-
type animals (Fig. 8C). These results indicated that DRG neurons
grown produce BDNF that is necessary for the survival of TrkA+/
TrkB+/Ret+ nociceptive neurons. In vivo, lack of BDNF possibly
produced within the ganglia themselves is needed for a fraction of
nociceptors (peptidergic and non-peptidergic) to survive.
Discussion
In the present study we have identiﬁed an essential dependence of
cutaneous nociceptive neurons on BDNF for survival. The requirement
for BDNF is observed immediately after birth and appears to last for a
period that encompasses the ﬁrst week of postnatal life, coincident
with the down-regulation in the expression of TrkA. In vitro, neurons
that express CGRP and/or IB4-binding sites survived in the presence
of BDNF. In vivo, lack of BDNF resulted in the loss of sensory afferents
with C-ﬁbres and in an overall decrease in the density of free nerve
endings in hairy and glabrous skin as well as in the dorsal horn of the
spinal cord, alongwith reduced numbers of IB4+ and CGRP+neurons
Fig. 7. Expression of NGF, BDNF and GDNF mRNA in skin and DRGs. (A) Quantitative
real-time PCR (Q-PCR) was used to determine the level of expression of NGF, BDNF and
GDNF in samples of skin from newborn (P0), 8-day-old (P8) and 15-day-old (P15)
mice. (B) Q-PCR was used to quantitate the expression of NGF, BDNF and GDNF in DRGs
obtained from P0, P8 and P15 mice. The graphs show that very little amounts of each
neurotrophin mRNA are expressed in the skin samples, whereas especially high
amounts of BDNF mRNA are expressed in DRGs harvested at P0, with decreasing
amounts in P8 and P15 (n=4). ⁎Pb0.05, ⁎⁎Pb0.005.
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postnatal survival is elicited by BDNF released by DRG neurons
themselves, in an auto/paracrine manner.
Early descriptions of the sensory phenotype of the various strains
of BDNF and trkB mutant mice generated in different laboratories
were somewhat confusing. Visceral sensory populations were clearly
shown to depend on BDNF and neurotrophin-4 (NT-4/5) acting on
their common receptor, TrkB, as neurons of the nodose–petrosal
ganglion complex disappeared in the absence of a catalytic TrkB
receptor or in double BDNF/NT-4/5 homozygous mutant mice
(Connover et al., 1995; Erickson et al., 1996; Silos-Santiago et al.,
1997; Brady et al., 1999; Erickson et al., 2001). Similar studies in DRGs,
however, rendered contradictory results. Initial studies indicated that
approximately 30%–35% of the DRG neurons were lost in 2-week-old
BDNF and trkB mutants (Klein et al., 1993; Jones et al., 1994; Ernfors
et al., 1994a, 1994b) and that NT-4/5 deﬁcient mice did not show any
neuron deﬁcits in the DRGs at birth (Liu et al., 1995; Connover et al.,
1995). The neuronal deﬁcit in the TrkB-deﬁcient animals was shown
to occur postnatally (Silos-Santiago et al., 1997) but analyses in other
strains described prenatal deﬁcits (Minichiello et al., 1995, Liebl et al.,
2000). In another report, BDNF appeared to regulate the sensitivity,
but not the survival, of hairy skin afferents (Carroll et al., 1998). More
recent analyses at the periphery have indicated that some cutaneous
sensory afferents are missing in the absence of TrkB-mediated BDNF
signalling. BDNF and trkB null postnatal mice lackMeissner corpuscles
(Gonzalez-Martínez et al., 2004, 2005) and a fraction of joint Pacinian
corpuscles (Sedý et al., 2004). Receptor analyses in the peridontal
ligament, the palate, or the whisker pad have also indicated thatRufﬁni afferents andMeissner corpuscles depend on BDNF for survival
(Fundin et al., 1997; Ichikawa et al., 2000; Alkhamrah et al., 2003).
Because peripheral sensory receptors appear to depend on sensory
afferent innervation for their differentiation (see Zelená, 1994, for a
review) these latter studies suggest that lack of BDNF may result in
deﬁcits in the numbers of sensory neurons. Our data demonstrate that
immediately after birth a fraction of nociceptors do also require BDNF
for survival.
We have observed that DRG neuron loss in BDNF-deﬁcient mice
occurs only postnatally. Despite the expression of TrkB receptors in
DRG neurons during development (Ernfors et al., 1992, Schecterson
and Bothwell, 1992; Mu et al., 1993; Fariñas et al., 1998), sensory
neuron loss in our BDNF mutants occurred after birth, as we did not
detect any deﬁcits in cell numbers during embryogenesis. BDNF
poorly supports the survival in vitro of sensory neurons isolated from
neonatal DRGs but BDNF responsiveness increases postnatally (see
also, Baudet et al., 2000). Therefore, the time-window for BDNF
actions on neuronal survival, both in the nociceptive and mechano-
receptive populations of sensory afferents, is likely restricted to
postnatal development. Because BDNFmutant mice usually die during
the ﬁrst hours of postnatal life and only a few survive up to P15–P21,
we could not analyze whether more neurons would be lost in the
maintained absence of BDNF. The phenotype of heterozygous BDNF
mutant mice, however, suggests that only 50% of nociceptors may be
dependent on BDNF.We observed a partial reduction of around 25% in
nociceptive afferent neurons in heterozygous mice, a deﬁcit which
resulted in alterations in the behavioral response of mutant animals to
pain stimuli. Partial losses of sensory neurons in neurotrophin
heterozygous mutant mice have been previously reported, i.e., the
loss of half the number of muscle spindles in NT-3+/−mice when NT-
3−/− completely lack these muscle receptors (Ernfors et al., 1994b).
These partial phenotypes have been interpreted as a demonstration
that neurotrophins are limiting under normal conditions. In this
particular case, the phenotype of the BDNF+/−mice also suggests that
BDNF may not be necessary for nociceptor survival in vivo past 2
weeks of life.
Some neurons depend exclusively on one neurotrophin, as for
instance, large diameter proprioceptive neurons which appear to
exclusively express the neurotrophin-3 (NT-3) receptor TrkC (Mu
et al., 1993) and to require only NT-3 to survive (Klein et al., 1994;
Fariñas et al., 1994; Ernfors et al., 1994a, 1994b; Tessarollo et al., 1994;
Tojo et al., 1995). In contrast, nociceptors appear to depend on the
sequential action of more than one neurotrophic factor. Duringmouse
embryogenesis all small DRG neurons express the TrkA receptor and
require NGF for survival and are completely lost in neonatal mice
deﬁcient in either NGF or its receptor TrkA, in which around 80% of all
DRG neurons disappear (Ruit et al., 1992; Crowley et al., 1994;
Smeyne et al., 1994; Silos-Santiago et al., 1995;White et al., 1996; Rice
et al., 1998). It appears likely that these NGF-dependent neurons also
depend on NT-3 at some point in embryogenesis because NT-3
deﬁcient mice lose around 70% of all neurons (Fariñas et al., 1996).
This requirement for NT-3 appears to be mediated by TrkA, because
trkC mutant mice only lose the population of large proprioceptive
neurons which constitute less than 20% of all neurons in the DRGs
(Klein et al., 1994; Fariñas et al., 1994, 1996). After birth, TrkA is still
present in peptidergic CGRP/SP-positive neurons and, therefore,
these neurons continue to be supported by NGF postnatally. However,
IB4-positive neurons down-regulate TrkA after birth and begin
expressing the GDNF receptor c-ret (Silos-Santiago et al., 1995;
Molliver et al., 1997; Bennett et al., 1998). This expression pattern led
to the idea that IB4+ nociceptors underwent a dependence switch in
neurotrophic factor requirement from NGF to GDNF postnatally
(Silos-Santiago et al., 1995; Molliver et al., 1997; Bennett et al.,
1998). It was shown that Ret expression and GDNF-elicited survival
responses increase after birth and that by P15 more than 50% of DRG
neurons can be supported in vitro by GDNF (Molliver et al., 1997;
Fig. 8. BDNF autocrine/paracrine effects. (A) Histogram showing the percentage of neuronal survival in three independent cultures in which sensory neurons cultured in 10 ng/ml
NGF were simultaneously treated with anti-BDNF antibodies or with a non-relevant IgG. Note that blockade of BDNF reduces the survival in NGF suggesting autocrine/paracrine
effects of this neurotrophin on NGF-dependent neurons (n=5). (B) Double staining of cultured neurons with CGRP antibodies (red) and IB4 lectin (green) in the different
conditions. (C) Histogram showing the percentage of neuronal survival in three independent cultures in which sensory neurons from Bdnf+/+ and Bdnf−/− neonatal mice were
cultured in 10 ng/ml each NGF, BDNF, or GDNF for 48 h. ⁎Pb0.05, ⁎⁎Pb0.005.
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is not very effective as a survival factor for embryonic/neonatal DRG
neurons (Matheson et al., 1997; Baudet et al., 2000) and that GDNF-
deﬁcient mice lose less than 25% of all DRG neurons at birth time
(Moore et al., 1996), a deﬁcit that appears to target preferentially
small size neurons as shown by cell size distribution analysis (Baudet
et al., 2000). More recently, the characterization of mice carrying a
conditional inactivation of Ret signalling has demonstrated that GDNF
is not essential for the survival of IB4+ neurons (Fundin et al., 1999;
Luo et al., 2007). Our present results demonstrate that BDNF does play
an essential role in the survival of nociceptors immediately after birth
and directly implicate BDNF as an important player in nociceptive
development, at times when part of the NGF-dependent nociceptors
are down-regulating TrkA.
GDNF expression in the neonatal skin is low or appears restricted to
speciﬁc structures (Golden et al., 1999; Fundin et al., 1999; Botchkareva
et al., 2000); however, cutaneous GDNF expression becomes more
prominent than expression of BDNF or NGF during postnatal develop-
ment. It has been shown thatGDNF also regulates nociceptor physiology
and innervation patterns in adult animals (Amaya et al., 2004; Malin et
al., 2006; Albers et al., 2006). Moreover, exogenous administration ofGDNF has been shown to prevent axotomy-induced changes in the
conduction velocity of IB4+ ﬁbres and to promote neurite outgrowth
fromDRG explants (Bennett et al., 1998; Leclere et al., 1998). Therefore,
GDNF plays an important role in the physiology of c-ret+ nociceptors
but it is not essential for their survival.
Our culture data indicate that some NGF-dependent DRG neurons
express TrkB and Ret and can, therefore, be supported in vitro by
BDNF or GDNF. The deﬁcits found in BDNF mutants indicate that the
relevant factor for survival in vivo is BDNF. Therefore, because BDNF
targets a population of cells that can also be maintained by NGF and
GNDF, the neuronal loss observed in vivo is likely due to differential
expression of these trophic factors during the early postnatal
developmental period. Thus, developmental dynamics of neuro-
trophic factor expression during skin development could explain
speciﬁc losses in neuronal populations despite the presence of the
corresponding receptor as it happens during inner ear development
(Fariñas et al., 2001).
BDNF is abundantly expressed within the ganglia at early
postnatal times, as shown by Q-PCR. BDNF expression has been
shown to be up-regulated in TrkA-positive nociceptors in response
to peripherally derived NGF, such as in cases of inﬂammation
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Michael et al., 1997). Moreover, BDNF produced and released by
neurons in adult DRGs appears to support the survival of sensory
neurons by an autocrine mechanism (Wright et al., 1992; Acheson
et al., 1995). Some of our data suggest the intriguing possibility that
NGF may also regulate the levels of TrkB although some more
experiments will be needed to demonstrate a more direct role of
NGF stimulation on TrkB expression. Our data are consistent with a
model in which NGF may regulate BDNF and TrkB expressions and
ganglion-derived BDNF ensures the survival of nociceptive neurons.
Interestingly, cutaneous BDNF overexpression results in enhanced
innervation to hair follicles, Meissner corpuscles, and Merkel cells
without changes in the number of sensory neurons in the DRGs
(LeMaster et al., 1999), suggesting that overexpression of BDNF in
the skin does not result in the rescue of DRG neurons postnatally.
Neurotrophins have been shown to exert differential actions when
acting on nerve endings or on cell bodies (Howe and Mobley, 2005).
Further studies will be necessary to determine whether BDNF
promotes survival and regulates neurite growth by acting on different
cell compartments.
BDNF exogenous brain administration has been shown to have an
anti-nociceptive effect either after chronic (Siuciak et al., 1994;
Siuciak et al., 1995) or acute infusions (Cirulli et al., 2000). It has been
proposed that this reduced pain sensitivity is a central response
elicited by a modulation of the actions of serotonin and several
neuropeptides, like SP and neuropeptide Y, by BDNF (Siuciak et al.,
1994; Siuciak et al., 1995). The anti-nociceptive effect of BDNF can be
antagonized by naloxone, suggesting the additional involvement of
opioid-linked systems in the analgesia produced by midbrain
infusions of BDNF (Siuciak et al., 1994). However, in clear contrast
with the observed antinociceptive effect of exogenous BDNF admin-
istration, our experiments and others (MacQueen et al., 2001) have
revealed that BDNF heterozygous mice exhibit thermal hypoalgesia in
the hot plate test under basal conditions. How low levels of BDNF
during development and high levels during adulthood can both result
in anti-nociception should be studied more in detail. Besides
differences in species (mice used in experiments of heterozygous and
rats used in BDNF infusion works) and the possibility of uncontrolled
variables that could modulate stress-induced analgesia (Wilson and
Mogil, 2001), the postnatal loss of nociceptive sensory cutaneous
afferents reported here could likely explain the increased latency in
thermal nociceptive perception in BDNFmutant mice.
Neurotrophin dependence in populations of peripheral neurons
has been extensively investigated. Surprisingly, the nociceptive
phenotype of the BDNF-deﬁcient strain of mice had remained elusive
despite previous analyses. Here, we demonstrate that BDNF is
essential for the survival of a fraction of nociceptors at perinatal
times when they are loosing their NGF dependence. These results
need to be taken into account when interpreting the consequences of
reduced levels of BDNF in pain physiology.
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